CTHRC1 and hepatocellular carcinoma: Hence, in the current study, we aimed to further investigate the role of miR-155 and CTHRC1 in the pathogenesis and progression of HCC and to clarify whether miR-155 and CTHRC1 have the potential to be new biomarkers for aggressive HCC and to be new therapeutic targets in treating HCC.